| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000030413 |
| Receipt No. | R000034728 |
| Official scientific title of the study | Investigation on time course of blood uric acid level after intake of nucleic acid containing food |
| Date of disclosure of the study information | 2019/04/01 |
| Last modified on | 2017/12/28 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Investigation on time course of blood uric acid level after intake of nucleic acid containing food | |
| Title of the study (Brief title) | Investigation on time course of blood uric acid level after intake of nucleic acid containing food | |
| Region |
|
|
| Condition | ||
| Condition | Normal healthy subjects | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Investigation on time course of blood uric acid level after intake of nucleic acid containing food |
| Basic objectives2 | Others |
| Basic objectives -Others | Investigation on intestinal absorption and metabolism of foodstuff |
| Trial characteristics_1 | Others |
| Trial characteristics_2 | Others |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Concentration of serum uric acid |
| Key secondary outcomes | Creatinine, LDL cholesterol level, HDL cholesterol level, neutral fat, total cholesterol level, blood glucose level |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | nucleic acid containing food | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Persons who have full ethical and regulatory approval and themselves and parental guardian give written informed consent
2.Healthy men and women who have serum uric acid value less than 8.0 mg / dL, and have never suffered a gout symptom 3.Healthy Japanese over 20 years old |
|||
| Key exclusion criteria | 1.Persons receiving medications such as uric acid levels, hypertension, diabetes, etc.
2.Pregnancy, breast-feeding, or pregnancy planning person 3.Those who are scheduled to undergo surgery / hospitalization, etc. for two months before and after the examination period (November 2017 to February 2018) |
|||
| Target sample size | 7 | |||
| Research contact person | |
| Name of lead principal investigator | Shuichi Segawa |
| Organization | SAPPORO HOLDINGS Ltd. |
| Division name | Frontier Laboratory for Value Creation |
| Address | 10 Okatohme, Yaizu city, Shizuoka, 425-0013 JAPAN |
| TEL | 054-629-7982 |
| Syuuichi.segawa@sapporoholdings.co.jp | |
| Public contact | |
| Name of contact person | Shuichi Segawa |
| Organization | SAPPORO HOLDINGS Ltd. |
| Division name | Frontier Laboratory for Value Creation |
| Address | 10 Okatohme, Yaizu city, Shizuoka, 425-0013 JAPAN |
| TEL | 054-629-7982 |
| Homepage URL | |
| Syuuichi.segawa@sapporoholdings.co.jp | |
| Sponsor | |
| Institute | SAPPORO HOLDINGS Ltd. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | SAPPORO HOLDINGS Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034728 |